-
公开(公告)号:SK13932000A3
公开(公告)日:2001-05-10
申请号:SK13932000
申请日:1999-04-20
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MOLLER ACHIM , TREIBER HANS-JORG , KNOPP MONIKA
IPC: C07D295/12 , A61K31/4402 , A61K31/4406 , A61K31/4418 , A61K31/4425 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4545 , A61K31/4725 , A61K31/496 , A61K31/506 , A61K31/5355 , A61K31/5375 , A61K31/5377 , A61K31/551 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/16 , A61P43/00 , C07D213/80 , C07D213/81 , C07D213/82 , C07D215/50 , C07D239/42 , C07D295/192 , C07D401/04 , C07D401/14 , C07D405/12 , C07D413/12 , C07D317/60 , C07D295/155 , A61K31/495 , A61K31/505 , A61K31/455
Abstract: Heterocyclically substituted amides of the general formula Iwherein the variables as defined in the specification are useful in pharmaceuticals for the treatment of diseases in which increased interleuken-1 levels occur.
-
公开(公告)号:ID26980A
公开(公告)日:2001-02-22
申请号:ID20002135
申请日:1999-04-19
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MOLLER ACHIM , TREIBER HANS-JORG , KNOPP MONIKA
IPC: A61K31/4164 , A61K31/426 , A61K31/4427 , A61K31/4439 , A61K31/444 , A61K31/455 , A61K31/4709 , A61K31/4725 , A61K31/4965 , A61K31/505 , A61K31/506 , A61K31/5377 , A61P9/04 , A61P9/08 , A61P9/10 , A61P13/12 , A61P21/00 , A61P25/00 , A61P25/08 , A61P25/28 , A61P27/12 , A61P43/00 , C07D213/81 , C07D213/82 , C07D233/90 , C07D239/28 , C07D239/30 , C07D239/42 , C07D241/28 , C07D277/20 , C07D277/44 , C07D277/56 , C07D401/04 , C07D401/12 , C07D413/12 , A61K31/44
Abstract: Amides of the general formula Iand their tautomeric and isomeric forms, possible enantiomeric and diastereomeric forms, as well as possible physiologically tolerable salts, in which the variables have the meanings stated in the description, their preparation and use as calpain inhibitors.
-
公开(公告)号:ID26305A
公开(公告)日:2000-12-14
申请号:ID20002113
申请日:1999-04-19
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MOLLER ACHIM , TREIBER HANS JORG , KNOPP MONIKA
IPC: C07D295/08 , A61K31/18 , A61K31/27 , A61K31/4409 , A61K31/4418 , A61P9/00 , A61P13/12 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/28 , A61P29/00 , A61P35/00 , A61P35/04 , A61P37/02 , A61P43/00 , C07C233/78 , C07C235/42 , C07C237/34 , C07C311/21 , C07D213/56 , C07D295/096 , A61K31/44
Abstract: Benzamides of the formula Iand its tautomeric forms, possible enantiomeric and diastereomeric forms, E and Z forms, and possible physiologically tolerated salts, in which the variables have the following meanings:R1-C1-C6-alkyl, branched or unbranched, where one of the C atoms in this chain may be substituted by a phenyl ring, cyclohexyl ring, indolyl ring and an SCH3 group, and the phenyl ring in turn is substituted by by [sic] a maximum of two R4 radicals, where R4 [lacuna] hydrogen, C1-C4-alkyl, branched or unbranched, -O-C1-C4-alkyl, OH, Cl, F, Br, I, CF3, NO2, NH2, CN, COOH, COO-C1-C4-alkyl, NHCO-C1-C4-alkyl, andR2 can be NR5CO-R6 and NHR5SO2-R6, andR3 is chlorine, bromine, fluorine, C1-C6-alkyl, NHCO-C1-C4-alkyl, NHSO2-C1-C4-alkyl, NO2, -O-C1-C4-alkyl, CN, COOH, CONH2, COO-C1-C4-alkyl, SO2-C1-C4-alkyl, -SO2Ph, SO2NH-C1-C4-alkyl, iodine, SO2NH2 and NH2, andA can be aromatic rings and heteroaromatic rings such as naphthyl, quinolyl, quinoxyl, benzimidazolyl, benzothienyl, quinazolyl, phenyl, thienyl, imidazolyl, pyridyl, pyrimidyl and pyridazyl, it also being possible for the rings to be substituted by by [sic] R9 and up to 2 R8 radicals, andB a bond, -(CH2)m-, -(CH2)m-O-(CH2)o-, -(CH2)o-S-(CH2)m-, -(CH2)o-SO-(CH2)m-, -(CH2)o-SO2-(CH2)m-, -CH=CH-, -C=C-, -CO-CH=CH-, -(CH2)o-CO-(CH2)m-, -(CH2)m-NHCO-(CH2)o-, -(CH2)m-CONH-(CH2)o-, -(CH2)m-NHSO2-(CH2)o-, -NH-CO-CH=CH-, -(CH2)m-SO2NH-(CH2)o-,A-B together alsoR5 hydrogen and C1-C4-alkyl andR6 is hydrogen, phenyl, naphthyl, C1-C6-alkyl, linear or branched, it being possible for a C atom in the chain to be substituted by a phenyl ring which itself may also be substituted by one or two R4 radicals, andR8 can be hydrogen, C1-C4-alkyl, branched or unbranched, -O-C1-C4-alkyl, OH, Cl, F, Br, I, CF3, NO2, NH2, CN, COOH, COO-C1-C4-alkyl, -NHCO-C1-C4-alkyl, phenyl, NHCO-phenyl, -NHSO2-C1-C4-alkyl, -NHSO2-phenyl, -SO2-C1-C4-alkyl, pyridine [sic] and SO2-phenyl,R9 hydrogen, -CHR14-(CH2)p-R12 where R12 pyrrolidine [sic], morpholine [sic], piperidine [sic], hexahydroazepine [sic], homopiperazine [sic], and R10 [lacuna] C1-C6-alkyl, branched or unbranched, and which may also carry a phenyl ring which is in turn substituted by by [sic] a maximum of two R11 radicals, where R11 is hydrogen, C1-C4-alkyl, branched or unbranched, -O-C1-C4-alkyl, OH, Cl, F, Br, I, CF3, NO2, NH2, CN, COOH, COO-C1-C4-alkyl, NHCO-C1-C4-alkyl, -NHSO2-C1-C4-alkyl and -SO2-C1-C4-alkyl; andR13 is hydrogen and C1-C6-alkyl, branched or unbranched, andn,p is [sic], independently of one another, a number 0, 1 or 2, andm,o is [sic], independently of one another, a number 0, 1, 2, 3 or 4.
-
公开(公告)号:CO4930264A1
公开(公告)日:2000-06-27
申请号:CO97060053
申请日:1997-10-14
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MOLLER ACHIM , DELZER JURGEN
IPC: A61K31/445 , A61K31/4523 , A61K31/4545 , A61K31/4709 , A61K31/498 , A61K31/5355 , A61P9/10 , A61P25/14 , A61P25/28 , A61P35/00 , A61P43/00 , C07D211/62 , C07D213/40 , C07D295/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D409/06 , C07D413/12 , C07D413/14
Abstract: Derivados de ácido piperidincetocarboxílico de lafórmula general I y sus formas tautómeras e isómeras, así como las sales fisiológicamente compatibles de los mismos, donde las variables tienen los significados siguientes: R1 -CO-R4 , -SO2 -R4 , -CONH-R4 , -COOR4 , -C(=N)-R4 , -C(=O)-NHR4 y -C(=S)-NHR4 ; R2 -C1 -C6 -alquilo, ramificado o sin ramificar, y que puede llevar aún un anillo fenilo, piridina o naftilo, que a su vez puede estar sustituido por, como máximo, dos radicales R5 , representando R5 C1 -C4 -alquilo, ramificado o sin ramificar, -O-C1 -C4 -alquilo, OH, Cl, F, Br, I, CF3 , NO2 , NH2 , CN, COOH, COO-C1 -C4 -alquilo, -NHCO-C1 -C4 - alquilo, -NHCOPh, -NHSO2 -C1 -C4 -alquilo, NHSO2 -Ph, -SO2 -C1 -C4 -alquilo y -SO2 Ph; R3 -OR6 y -NHR6 ; R4 -C1 -C6 -alquilo, ramificado o sin ramificar, pudiendo una cadena de dos o más átomos de carbono llevar también un doble enlace o un triple enlace y estar sustituido por uno o dos anillos, tales como fenilo, naftalina, quinoxalina, quinolina, isoquinolina, piridina, tiofeno, pirimidina, tiazol, isotiazol, triazol, imidazol, ciclohexilo, ciclopentilo, fluoreno, indol, benzimidazol, oxazol, isooxazol y furano, pudiendo cada uno de los anillos mismos llevar, como máximo, dos radicales R5 ; R6 hidrógeno, un anillo fenilo que puede llevaraún uno o dos radicales R5 , C1 -C6 -alquilo, ramificado o sin ramificar, que puede contener un doble enlace o por un triple enlace, y un anillo fenilo, naftalina, piridina, pirimidina, piperidina, pirrolidina, morfolina tiofeno, quinolina e isoquinolina, pudiendo los anillos aromáticos llevar aún, como máximo, dos radicales -NR7 R8 o R5 , donde R7 y R8 representan, cada uno independientemente del otro hidrógeno o C1 -C6 -alquilo, ramificado o sin ramificar.
-
公开(公告)号:NZ335981A
公开(公告)日:2000-04-28
申请号:NZ33598197
申请日:1997-11-28
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MOLLER ACHIM , TREIBER HANS-JORG
IPC: C07D295/12 , A61K31/16 , A61K31/166 , A61K31/381 , A61K31/40 , A61K31/4164 , A61K31/4402 , A61K31/4409 , A61K31/4439 , A61K31/4453 , A61K31/4468 , A61K31/4545 , A61K31/47 , A61K31/4709 , A61K31/495 , A61K31/496 , A61K31/498 , A61K31/5355 , A61K31/5375 , A61K31/5377 , A61P9/10 , A61P25/00 , A61P25/08 , A61P25/28 , A61P35/00 , A61P43/00 , C07C233/87 , C07C237/22 , C07C237/36 , C07C237/42 , C07C311/19 , C07C311/21 , C07D211/58 , C07D213/56 , C07D215/12 , C07D215/36 , C07D215/48 , C07D233/54 , C07D233/61 , C07D241/42 , C07D241/44 , C07D295/02 , C07D295/13 , C07D333/38 , C07D333/56 , C07D333/60 , C07D401/12 , C07D521/00 , C07K5/02 , A61K31/165 , A61K31/435
Abstract: The disclosure relates to ketobenzamide compounds of formula (I) and their use as inhibitors of cystine proteases and the treatment of disorders in which increased calpin activity occurs.
-
16.
公开(公告)号:NZ335066A
公开(公告)日:2000-03-27
申请号:NZ33506697
申请日:1997-11-28
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MOLLER ACHIM , TREIBER HANS-JORG
IPC: A61K31/403 , A61K31/4035 , A61K31/405 , A61K31/4439 , A61K31/496 , A61K31/517 , A61K31/519 , A61K31/5377 , A61P9/00 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/28 , A61P35/00 , A61P35/04 , A61P43/00 , C07D209/48 , C07D209/66 , C07D239/70 , C07D239/96 , C07D401/12 , C07D471/04 , C07D475/02 , A61K31/505 , A61K31/40
Abstract: Heterocyclic substituted benzamide of the formula 1 where R1 is H, C1-6 alkyl, O-C1-C6-alkyl, OH, Cl, F, Br, I, CF3, NO2, NH2, CN, COOH, COO-C1-C4-alkyl, -NHCO-C1-C4-alkyl, NHCO-phenyl, -CONHR8, NHSO2-C1-4-alkyl, -NHSO2-phenyl, -SO2-C1-4-alkyl or -SO2-phenyl, R2 is H, C1-6 alkyl, O-C1-C6-alkyl, OH, Cl, F, Br, I, CF3, NO2, NH2, CN, COOH, COO-C1-C4-alkyl, -NHCO-C1-C4-alkyl, NHCO-phenyl, -CONHR8, NHSO2-C1-4-alkyl, -NHSO2-phenyl, -SO2-C1-4-alkyl or -SO2-phenyl, R1 and R2 are together, a chain -CH=CH-CH=CH-, which can additionally carry one or two substituents R6 R3 is H, Cl, Br, F, C1-6-alkyl, phenyl, NHCO-C1-4-alkyl, NO2 or NH2, R4 is C1-6-alkyl, which can be optionally substituted phenyl and other aromatic rings substituted by R7 R5 is H, -CO-OR8, -CO-Nr9R10, or formulas, 2, 3, 4 or 5 where R12 is H, or a C0-4-alkyl chain which can be substituted by a phenyl ring which can itself carry one or two radicals R11. These compounds are used for inhibitors of cysteine proteases, elevated levels of calpain, and neurogenerative diseases.
-
公开(公告)号:TR9901191T2
公开(公告)日:1999-12-21
申请号:TR9901191
申请日:1997-11-11
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MOLLER ACHIM , TREIBER HANS-JORG
IPC: A61K31/16 , A61K31/166 , A61K31/18 , A61K31/4045 , A61K31/435 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/47 , A61P9/10 , A61P21/00 , A61P25/00 , A61P25/08 , A61P25/28 , A61P27/00 , A61P35/00 , A61P35/04 , A61P43/00 , C07C233/76 , C07C235/42 , C07C235/46 , C07C235/58 , C07C235/60 , C07C235/84 , C07C237/42 , C07C311/08 , C07C311/21 , C07C317/44 , C07C323/42 , C07C323/60 , C07D209/14 , C07D209/16 , C07D213/30 , C07D213/56 , C07D213/71 , C07D213/82 , C07D215/36
CPC classification number: C07D213/82 , C07C233/76 , C07C235/42 , C07C235/46 , C07C235/60 , C07C235/84 , C07C237/42 , C07C311/21 , C07C317/44 , C07C323/42 , C07C323/60 , C07C2601/14 , C07D209/16 , C07D215/36
-
公开(公告)号:SK74599A3
公开(公告)日:1999-12-10
申请号:SK74599
申请日:1997-11-28
Applicant: BASF AG
Inventor: LUBISCH WILFRIED , MOLLER ACHIM
IPC: C07D295/12 , A61K31/16 , A61K31/166 , A61K31/381 , A61K31/40 , A61K31/4164 , A61K31/4402 , A61K31/4409 , A61K31/4439 , A61K31/4453 , A61K31/4468 , A61K31/4545 , A61K31/47 , A61K31/4709 , A61K31/495 , A61K31/496 , A61K31/498 , A61K31/5355 , A61K31/5375 , A61K31/5377 , A61P9/10 , A61P25/00 , A61P25/08 , A61P25/28 , A61P35/00 , A61P43/00 , C07C233/87 , C07C237/22 , C07C237/36 , C07C237/42 , C07C311/19 , C07C311/21 , C07D211/58 , C07D213/56 , C07D215/12 , C07D215/36 , C07D215/48 , C07D233/54 , C07D233/61 , C07D241/42 , C07D241/44 , C07D295/02 , C07D295/13 , C07D333/38 , C07D333/56 , C07D333/60 , C07D401/12 , C07D521/00 , C07K5/02
Abstract: Disclosed are compounds of general formula (I) and their tau tomeric and isomeric forms, optionally their physiologically acce ptable salts, where the meaning of the substituents is stated in the description. Disclosed is their use for preparation of medica ments to treat the diseases, in which the increased activities of calpain occur. For example ischemic disease of heart, kidneys or central nervous system, inflammations, muscular dystrophy, catar act, etc.
-
公开(公告)号:CA2333008A1
公开(公告)日:1999-12-02
申请号:CA2333008
申请日:1999-05-25
Applicant: BASF AG
Inventor: KNOPP MONIKA , MOLLER ACHIM , TREIBER HANS-JORG , LUBISCH WILFRIED
IPC: C07D215/08 , A61K31/403 , A61K31/4035 , A61K31/404 , A61K31/4427 , A61K31/4433 , A61K31/4439 , A61K31/4545 , A61K31/47 , A61K31/472 , A61K31/4725 , A61K31/496 , A61K31/497 , A61K31/5377 , A61P9/08 , A61P9/10 , A61P13/12 , A61P21/00 , A61P21/04 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/28 , A61P27/12 , A61P29/00 , A61P35/00 , A61P35/04 , A61P43/00 , C07D209/14 , C07D209/44 , C07D215/06 , C07D217/06 , C07D217/14 , C07D401/04 , C07D401/14 , C07D403/04 , C07D409/14 , C07D217/04 , A61K31/40 , A61K31/44 , A61K31/495
Abstract: The invention relates to new amides of the general formula (I) and to their tautomeric and isomeric forms, possible enantiomeric and diastereomeric form s, as well as possible physiologically compatible salts, where the variables ha ve the meaning given in the description.
-
公开(公告)号:CA2328440A1
公开(公告)日:1999-10-28
申请号:CA2328440
申请日:1999-04-20
Applicant: BASF AG
Inventor: TREIBER HANS-JORG , KNOPP MONIKA , MOLLER ACHIM , LUBISCH WILFRIED
IPC: C07D295/12 , A61K31/4402 , A61K31/4406 , A61K31/4418 , A61K31/4425 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4545 , A61K31/4725 , A61K31/496 , A61K31/506 , A61K31/5355 , A61K31/5375 , A61K31/5377 , A61K31/551 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/16 , A61P43/00 , C07D213/80 , C07D213/81 , C07D213/82 , C07D215/50 , C07D239/42 , C07D295/192 , C07D401/04 , C07D401/14 , C07D405/12 , C07D413/12 , C07D295/155 , A61K31/44 , A61K31/455 , A61K31/495 , A61K31/505 , C07D317/60
Abstract: The invention relates to heterocyclically substituted amides of the general formula (I), their tautomeric and isomeric forms, their enantiomeric and diastereomeric forms and to physiologically compatible salts thereof, where the variables have the meanings given in claim 1, which are suitable as enzyme inhibitors, especially of cysteine proteinases such as calpain and cathepsins.
-
-
-
-
-
-
-
-
-